All Peter Lawætz Andersen articles

  • chemist-2815640_1280
    News

    Novo Nordisk Foundation partners with CARB-X to fight drug-resistant infections

    2024-01-09T12:00:00Z

    The Novo Nordisk Foundation is committing up to $25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this ...